Status:
NOT_YET_RECRUITING
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hepatitis B Vaccination
Immune Response
Eligibility:
All Genders
18+ years
Brief Summary
296 million people worldwide are infected with the hepatitis B virus (HBV), despite the existence of an effective prophylactic vaccine. Current treatments (nucleoside analogues and pegylated interfero...
Eligibility Criteria
Inclusion
- Adults ≥18 years
- Pre-vaccination HBV serology carried out within 4 weeks prior to vaccination
- Collection of no objection
Exclusion
- Opposition of the person or inability to give opposition
- Pregnant or breast-feeding women
- Chronic illnesses affecting the individual's immune system (asplenia; hyposplenia; haematological cancer; auto-immune disease requiring immunosuppressive treatment, HIV infection).
- Non-affiliation with a social security scheme, Universal Medical Coverage or any equivalent scheme
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT06876467
Start Date
April 1 2025
End Date
July 1 2028
Last Update
March 14 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.